Mankind Pharma will acquire Panacea’s formulations

Mankind Pharma is set to acquire Panacea Biotec Pharma’s formulations for an estimated Rs 1872 crores.

Mankind Pharma is set to acquire Panacea Biotec Pharma’s formulations for an estimated Rs 1872 crores. Mankind Pharma will be able to use Panacea’s formulations in India and Nepal markets. With this acquisition, Mankind Pharma will be able to explore and integrate novel therapeutic areas like lifestyle, oncology and transplant business.

An update claims that the shared of Panacea Biotec zoomed by 5% to Rs 198.50. Before it was Rs 197.10. Panacea has created a niche in the chronic and transplant business and their products are inherently backed up with thorough R&D and are supported by highly complex and distinctive technology. They hold the right to manufacture the Sputnik V Covid-19 vaccine.

Panacea Biotec Pharma is a subsidy of Panacea Biotec. The Serum Institute of India owned 8.59% stakes in this. In December 2021, sold 358,000 of its equity shares on NSE at Rs 278.15. Beleaguered Panacea Biotec was noticeably struggling to repay its debt of Rs 750 crore to Piramal Enterprises and India Resurgence Fund or IndiaRF.

Tags : #MankindPharma #PanaceaBiotecPharma #pharmacy #formulations #acquisitions #healthacqusition #alert #smitakumar #medicircle

Related Stories

Loading Please wait...

Trending Now

China ropes in more countries for its COVID-19 vaccine trialsSeptember 29, 2020
Antarctica is still free of Covid-19. Can it stay that way?September 29, 2020
Over 200 travellers from India barred from Dubai flight over invalid Covid-19 testsSeptember 29, 2020
Netherland focuses on more stricker rule to comabt COVID-19 September 29, 2020
WHO aims to provide 120 Million rapid Coronavirus tests for poorer statesSeptember 29, 2020
UN chief on 1 Million COVID-19 deathsSeptember 29, 2020
Bahrain reports 585 Covid-19 cases, 777 recoveriesSeptember 28, 2020
Bringing hepatitis C testing and treatment to underserved communities in MadridSeptember 28, 2020
Polish doctor recovers from severe COVID-19 through rehabilitationSeptember 28, 2020
WHO supports rehabilitation of COVID-19 and other patients in UkraineSeptember 28, 2020
WHO work with migrant camps in Greece September 28, 2020
US employers being sued for COVID-19 infection spread September 28, 2020
Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission :WHOSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020
Johnson & Johnson COVID-19 vaccine produces strong results September 26, 2020
New York to permanently switch to outdoor dining amid pandemicSeptember 26, 2020
WHO gave blessing for Coronavirus vaccine emergency use programme: ChinaSeptember 26, 2020
US surpasses 7 Million Coronavirus casesSeptember 26, 2020